ENDRA Life Sciences (NDRA) Common Equity (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Common Equity of $6.31 million for Q2 2026, up 328.3% from $1.47 million a year earlier and up 253.1% from the prior quarter.
ENDRA Life Sciences (NDRA) Common Equity (2016 - 2026) Analysis & Trends
At the end of FY2025, ENDRA Life Sciences posted Common Equity of $2.26 million, down 11.7% from FY2024.
- Common Equity has declined for four consecutive years, with a five-year compound annual growth rate of -20.6% (FY2020 to FY2025).
- By year, Common Equity came in at $2.56 million in FY2024 (-54.8%), $5.66 million in FY2023 (-21.5%), $7.2 million in FY2022 (-33.2%) and $10.78 million in FY2021 (+50.4%).
- The Q2 2026 figure ranks as the highest quarterly Common Equity since Q3 2024.
- Year over year, Common Equity gained in three of the last eight quarters, with growth averaging 7.2%.
- The high point for year-over-year Common Equity in five years was Q2 2026 (growth of 328.3%); the low point was Q3 2025 (a decline of 97.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.79 million (Q1 2026), $2.26 million (Q4 2025) and $171,380 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.28 Bn | 236.31 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 171.27 Bn | 141.70 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 162.70 Bn | 146.51 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 151.73 Bn | 131.15 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 119.67 Bn | 84.93 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 114.00 Bn | 100.12 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 65.33 Bn | 60.10 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Becton Dickinson | 53.51 Bn | 50.66 Bn | 2.32 Bn | 24.42 Bn |
| 9 | Edwards Lifesciences | 50.94 Bn | 34.94 Bn | 1.35 Bn | 10.72 Bn |
| 10 | ENDRA Life Sciences | 6.13 Mn | 2.48 Mn | - | 6.31 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.31 Mn |
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 171,380.00 |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Sep 30, 2024 | 6.60 Mn |
| Jun 30, 2024 | 8.99 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 5.66 Mn |
| Sep 30, 2023 | 5.20 Mn |
| Jun 30, 2023 | 6.93 Mn |
| Mar 31, 2023 | 4.50 Mn |
| Dec 31, 2022 | 7.20 Mn |
| Sep 30, 2022 | 10.20 Mn |
| Jun 30, 2022 | 13.33 Mn |
| Mar 31, 2022 | 9.07 Mn |
| Dec 31, 2021 | 10.78 Mn |
| Sep 30, 2021 | 13.16 Mn |
ENDRA Life Sciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NDRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NDRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NDRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();